Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study is a research paper published in Clinical Gastroenterology and Hepatology (2023). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K23KD111995-01A1
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK117058
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R03DK129631